Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Neurooncol ; 156(3): 615-623, 2022 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-34994963

RESUMO

BACKGROUND: Adult thalamic gliomas are a rare entity whose management is challenging for physicians. The aim of this study is to describe the characteristics and prognostic factors of thalamic gliomas in adult patients. METHODS: We retrospectively analyzed the clinical, neuro-radiological, histological, and molecular characteristics of all cases of adult thalamic glioma in our regional center. RESULTS: We included 38 adult patients. Median age at diagnosis was 56.5 years old (range, 24-80). Median KPS at diagnosis was 70%. Two-thirds of patients presented with tumor necrosis on MRI. Bithalamic lesions were present in four patients. The median volume of enhancement associated with lesions was relatively small (14 mm3). Two patients had undergone partial surgical resection. All other patients underwent biopsy. Median PFS was 7.1 months (95% CI [3.7-10.5]) and median OS was 15.6 months (95% CI [11.7-19.6]). Among 20 patients with available tumor samples for molecular analyses, only 4 (20%) presented with H3K27M mutation. Patients with H3K27M mutation had longer survival compared to those without. Finally, we identified a long-term survivor population characterized by a younger age, no cognitive impairment, low steroid dose treatment and the presence of H3K27M mutation. CONCLUSION: Thalamic adult glioma differs from bithalamic glioma in children with regards to its clinical, radiological and molecular profiles. Long-term survival is observed in young patients with limited symptoms and H3K27M mutation. A larger prospective cohort is needed to validate these findings.


Assuntos
Neoplasias Encefálicas , Glioma , Histonas , Adulto , Neoplasias Encefálicas/genética , Neoplasias Encefálicas/terapia , Glioma/genética , Glioma/terapia , Histonas/genética , Humanos , Mutação , Prognóstico , Estudos Retrospectivos , Tálamo/patologia
2.
Behav Neurol ; 2014: 154631, 2014.
Artigo em Inglês | MEDLINE | ID: mdl-25100900

RESUMO

BACKGROUND: Thalamic lesions are seen in a multitude of disorders including vascular diseases, metabolic disorders, inflammatory diseases, trauma, tumours, and infections. In some diseases, thalamic involvement is typical and sometimes isolated, while in other diseases thalamic lesions are observed only occasionally (often in the presence of other typical extrathalamic lesions). SUMMARY: In this review, we will mainly discuss the MRI characteristics of thalamic lesions. Identification of the origin of the thalamic lesion depends on the exact localisation inside the thalamus, the presence of extrathalamic lesions, the signal changes on different MRI sequences, the evolution of the radiological abnormalities over time, the history and clinical state of the patient, and other radiological and nonradiological examinations.


Assuntos
Neuroimagem , Doenças Talâmicas/patologia , Tálamo/patologia , Infarto Encefálico/complicações , Infarto Encefálico/patologia , Lesões Encefálicas/complicações , Lesões Encefálicas/patologia , Neoplasias Encefálicas/complicações , Neoplasias Encefálicas/patologia , Calcinose/complicações , Calcinose/patologia , Doenças Desmielinizantes/complicações , Doenças Desmielinizantes/patologia , Encefalite/complicações , Encefalite/patologia , Humanos , Infecções/complicações , Infecções/patologia , Imageamento por Ressonância Magnética , Doenças Metabólicas/complicações , Doenças Metabólicas/patologia , Necrose/complicações , Necrose/patologia , Síndrome da Leucoencefalopatia Posterior/complicações , Síndrome da Leucoencefalopatia Posterior/patologia , Estado Epiléptico/complicações , Estado Epiléptico/patologia , Doenças Talâmicas/complicações
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA